
  
    
      
        Background_NNP
        The_DT metabolic_JJ syndrome_NN is_VBZ a_DT condition_NN that_WDT promotes_VBZ
        atherosclerosis_NNS and_CC increases_VBZ the_DT risk_NN of_IN cardiovascular_JJ
        events_NNS [_NN 1_CD 2_CD 3_CD ]_NN ._. According_VBG to_TO the_DT Centers_NNPS for_IN Disease_NNP
        Control_NNP and_CC Prevention_NNP ,_, at_IN least_JJS 47_CD million_CD Americans_NNPS ,_, or_CC
        about_IN one_CD in_IN five_CD people_NNS ,_, have_VBP this_DT condition_NN [_NN 1_CD ]_NN ._.
        Contributors_NNP to_TO the_DT development_NN of_IN the_DT metabolic_JJ syndrome_NN
        may_MD include_VB genetics_NNS ,_, a_DT sedentary_JJ lifestyle_NN ,_, a_DT Western_JJ diet_NN
        (_( high_JJ in_IN refined_VBN carbohydrates_NNS ,_, low_JJ in_IN fiber_NN ,_, and_CC high_JJ in_IN
        saturated_VBD fat_JJ )_) ,_, cigarette_NN smoking_NN ,_, and_CC progressive_JJ weight_NN
        gain_NN [_NN 2_CD ]_NN ._. The_DT characteristics_NNS of_IN the_DT metabolic_JJ syndrome_NN
        include_VBP atherogenic_JJ dyslipidemia_NN ,_, a_DT prothrombotic_JJ state_NN ,_,
        insulin_NN resistance_NN ,_, hypertension_NN ,_, and_CC abdominal_NN obesity_NN [_NN 3_CD
        4_CD ]_NN ._. Each_DT abnormality_NN promotes_VBZ atherosclerosis_NNS
        independently_RB ,_, but_CC when_WRB clustered_VBN together_RB ,_, these_DT metabolic_JJ
        disorders_NNS are_VBP increasingly_RB atherogenic_JJ and_CC enhance_VB the_DT risk_NN
        of_IN cardiovascular_JJ morbidity_NN and_CC mortality_NN [_NN 1_CD ]_NN ._. Based_VBN on_IN
        observational_NN studies_NNS there_RB is_VBZ evidence_NN to_TO support_VB that_IN
        several_JJ factors_NNS related_VBN to_TO lifestyle_NN habits_NNS may_MD influence_VB
        cardiovascular_JJ risk_NN [_NN 5_CD 6_CD 7_CD ]_NN ._. Among_IN these_DT factors_VBZ the_DT
        beneficial_JJ effect_NN of_IN several_JJ dietary_JJ patterns_NNS on_IN human_JJ
        health_NN ,_, have_VBP already_RB been_VBN underlined_VBD [_NN 8_CD 9_CD 10_CD ]_NN ._. One_CD of_IN
        these_DT diets_NNS ,_, the_DT Mediterranean_NNP diet_NN ,_, has_VBZ received_VBN much_JJ
        attention_NN during_IN the_DT past_JJ decades_NNS ._. It_PRP is_VBZ reach_VB in_IN
        non-refined_JJ cereals_NNS ,_, fruits_NNS and_CC vegetables_NNS ,_, and_CC it_PRP has_VBZ a_DT
        high_JJ monounsaturated_JJ :_: saturated_VBD fat_JJ ratio_NN ._. Although_IN the_DT
        benefits_NNS from_IN the_DT adoption_NN of_IN this_DT diet_NN on_IN all_DT cause_VBP
        survival_NN have_VBP long_RB been_VBN recognized_VBN ,_, little_JJ is_VBZ known_VBN about_IN
        its_PRP$ association_NN with_IN the_DT development_NN of_IN acute_JJ coronary_JJ
        events_NNS ,_, in_IN people_NNS with_IN the_DT metabolic_JJ syndrome_NN ._. In_IN this_DT
        work_NN ,_, we_PRP evaluated_VBD the_DT effect_NN of_IN the_DT adoption_NN of_IN
        Mediterranean_NNP diet_NN on_IN the_DT risk_NN of_IN developing_VBG non-fatal_JJ
        acute_JJ coronary_JJ events_NNS ,_, in_IN subjects_NNS with_IN metabolic_JJ
        syndrome_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Study_NNP 's_POS population_NN
          The_DT CARDIO_NNP 2000_CD is_VBZ a_DT multicentre_NN case-control_JJ study_NN
          that_WDT investigates_VBZ the_DT association_NN between_IN several_JJ
          demographic_JJ ,_, nutritional_JJ ,_, lifestyle_NN and_CC medical_JJ risk_NN
          factors_NNS with_IN the_DT risk_NN of_IN developing_VBG non-fatal_JJ acute_JJ
          coronary_JJ syndromes_NNS ._. From_IN January_NNP 2000_CD to_TO August_NNP 2001_CD ,_, 848_CD
          individuals_NNS who_WP had_VBD just_RB entered_VBN to_TO the_DT hospital_NN for_IN a_DT
          first_JJ event_NN of_IN coronary_JJ heart_NN disease_NN (_( stable_JJ angina_NN was_VBD
          excluded_VBN from_IN the_DT analysis_NN )_) agreed_VBD to_TO participate_VB into_IN
          the_DT study_NN (_( response_NN rate_NN 89_CD %_NN )_) ._. Six_CD hundred_CD fifty-eight_JJ
          (_( 77_CD %_NN )_) of_IN them_PRP were_VBD males_NNS (_( 59_CD ._. 0_CD ±_NN 10_CD years_NNS old_JJ )_) and_CC 190_CD
          (_( 23_CD %_NN )_) were_VBD females_NNS (_( 65_CD ._. 3_LS ±_NN 9_CD years_NNS old_JJ )_) ._. The_DT inclusion_NN
          criteria_NNS for_IN cardiac_JJ patients_NNS are_VBP :_:
          •_NN First_CD event_NN of_IN acute_JJ myocardial_NN infarction_NN diagnosed_VBN
          by_IN two_CD or_CC more_JJR of_IN the_DT following_JJ features_NNS :_: typical_JJ
          electrocardiographic_JJ changes_NNS ,_, compatible_JJ clinical_JJ
          symptoms_NNS ,_, specific_JJ diagnostic_JJ enzyme_NN elevations_NNS ,_, or_CC
          •_NN First_CD diagnosed_VBN unstable_JJ angina_NN corresponding_JJ to_TO
          class_NN III_NNP of_IN the_DT Braunwald_NNP classification_NN ._.
          Moreover_RB ,_, 1078_CD randomly_RB selected_VBN cardiovascular_JJ
          disease_NN free_JJ subjects_NNS (_( controls_NNS )_) ,_, frequency_NN matched_VBN to_TO
          the_DT patients_NNS by_IN age_NN (_( ±_NN 3_CD years_NNS )_) ,_, sex_NN ,_, and_CC region_NN agreed_VBD
          to_TO participate_VB (_( response_NN rate_NN 83_CD %_NN )_) ._. Eight_CD hundred_CD and_CC
          thirty_CD (_( 77_CD %_NN )_) of_IN them_PRP were_VBD males_NNS (_( 58_CD ._. 0_CD ±_NN 10_CD years_NNS old_JJ )_) and_CC
          248_CD (_( 23_CD %_NN )_) were_VBD females_NNS (_( 64_CD ._. 8_CD ±_NN 9_CD years_NNS old_JJ )_) ._. Controls_NNP
          were_VBD individuals_NNS who_WP visited_VBD the_DT outpatients_NNS departments_NNS
          of_IN the_DT same_JJ hospital_NN and_CC at_IN the_DT same_JJ period_NN with_IN the_DT
          coronary_JJ patients_NNS for_IN minor_JJ surgical_JJ operations_NNS ._. All_DT the_DT
          controls_NNS were_VBD subjects_NNS without_IN any_DT clinical_JJ symptoms_NNS ,_,
          signs_NNS or_CC any_DT suspicion_NN of_IN cardiovascular_JJ disease_NN in_IN their_PRP$
          medical_JJ history_NN ,_, as_IN a_DT physician_NN evaluated_VBD it_PRP ._. We_PRP used_VBD
          this_DT type_NN of_IN controls_NNS in_IN order_NN to_TO have_VB more_RBR accurate_JJ
          medical_JJ information_NN ,_, to_TO eliminate_VB the_DT potential_JJ adverse_JJ
          effect_NN of_IN several_JJ ,_, unknown_JJ ,_, confounders_NNS and_CC to_TO increase_VB
          the_DT likelihood_NN that_IN cases_NNS and_CC controls_NNS share_VBP the_DT same_JJ
          study_NN base_NN [_NN 11_CD ]_NN ._. The_DT number_NN of_IN the_DT participants_NNS was_VBD
          decided_VBN through_IN power_NN analysis_NN ,_, in_IN order_NN to_TO evaluate_VB
          differences_NNS in_IN the_DT coronary_JJ relative_JJ risk_NN greater_JJR than_IN 7_CD %_NN
          (_( statistical_JJ power_NN >_NN 0_CD ._. 80_CD ,_, significant_JJ level_NN <_NN
          0_CD ._. 05_CD )_) ._.
        
        
          Stratification_NNP
          According_VBG to_TO the_DT population_NN distribution_NN provided_VBN by_IN
          the_DT National_NNP Statistical_NNP Services_NNPS (_( census_NN 2000_CD )_) ,_, we_PRP
          stratified_JJ our_PRP$ sampling_VBG into_IN all_PDT the_DT Greek_JJ regions_NNS ,_, in_IN
          order_NN to_TO include_VB various_JJ socio-economical_JJ levels_NNS and_CC
          cultural_JJ particularities_NNS of_IN the_DT investigated_VBN population_NN ._.
          The_DT enrolled_VBD subjects_NNS are_VBP from_IN ,_, approximately_RB ,_, the_DT one_CD
          half_NN of_IN the_DT clinics_NNS ,_, public_NN or_CC private_JJ ,_, of_IN the_DT two_CD
          biggest_JJS metropolitan_JJ cities_NNS (_( Athens_NNP and_CC Thessalonica_NNP )_) ,_,
          and_CC from_IN ,_, almost_RB ,_, all_PDT the_DT major_JJ clinics_NNS of_IN the_DT other_JJ
          regions_NNS (_( 3_CD from_IN Sterea_NNP Ellada_NNP ,_, 3_CD from_IN Thessalia_NNP ,_, 2_CD from_IN
          Hpeiros_NNP ,_, 5_CD from_IN Macedonia_NNP ,_, 2_CD from_IN Thrace_NNP ,_, 5_CD from_IN
          Peloponnese_NNP ,_, 2_CD from_IN Crete_NNP ,_, 5_CD from_IN Aegean_NNP and_CC 3_CD from_IN
          Ionian_NNP islands_NNS )_) ._.
        
        
          Randomised_NNP procedure_NN
          In_IN order_NN to_TO reduce_VB the_DT unbalanced_JJ distribution_NN of_IN
          several_JJ measured_VBN or_CC unmeasured_JJ confounders_NNS ,_, both_DT patients_NNS
          and_CC controls_NNS were_VBD randomly_RB selected_VBN ._. Thus_RB ,_, a_DT sequence_NN of_IN
          random_JJ numbers_NNS (_( 1_CD ._. ._. ._. 0_CD )_) was_VBD applied_VBN in_IN the_DT hospitals_NNS '_POS
          admission_NN listings_NNS ._. The_DT coronary_JJ patients_NNS who_WP assigned_VBN to_TO
          the_DT number_NN 1_CD were_VBD entered_VBN into_IN the_DT study_NN and_CC interviewed_VBN
          (_( i_NNP ._. e_SYM ._. approximately_RB the_DT one_CD half_NN of_IN the_DT cardiac_JJ patients_NNS
          that_WDT visited_VBD each_DT cardiology_NN clinic_NN )_) ._. The_DT same_JJ procedure_NN
          was_VBD applied_VBN for_IN the_DT controls_NNS ,_, after_IN taking_VBG into_IN account_NN
          the_DT matching_VBG criteria_NNS ._.
        
        
          Investigated_NNP parameters_NNS
          A_DT specialist_NN retrieved_VBD the_DT information_NN regarding_VBG the_DT
          investigated_VBN medical_JJ factors_NNS from_IN the_DT subjects_NNS '_POS medical_JJ
          records_NNS ,_, and_CC the_DT information_NN regarding_VBG the_DT life_NN style_NN
          characteristics_NNS through_IN a_DT confidential_JJ questionnaire_NN
          during_IN a_DT specific_JJ interview_NN after_IN the_DT 2_CD ndday_NN of_IN the_DT
          hospitalisation_NN ,_, for_IN the_DT cases_NNS and_CC at_IN entry_NN for_IN the_DT
          controls_NNS ._. The_DT evaluation_NN of_IN the_DT nutritional_JJ habits_NNS was_VBD
          based_VBN on_IN a_DT nutrient_NN questionnaire_NN according_VBG to_TO the_DT
          guidelines_NNS from_IN the_DT Department_NNP of_IN Nutrition_NNP of_IN the_DT
          National_NNP School_NNP of_IN Public_NNP Health_NNP [_NN 12_CD ]_NN ._. The_DT
          Mediterranean_NNP dietary_JJ pattern_NN consists_VBZ of_IN :_: (_( a_DT )_) daily_JJ
          consumption_NN :_: of_IN non_NN refined_VBN cereals_NNS and_CC products_NNS (_( whole_JJ
          grain_NN bread_NN ,_, pasta_NN ,_, brown_JJ rice_NN ,_, etc_FW )_) ,_, vegetables_NNS (_( 2_CD -_: 3_CD
          servings_NNS /_NN day_NN )_) ,_, fruits_NNS (_( 6_CD servings_NNS /_NN day_NN )_) ,_, olive_JJ oil_NN (_( as_IN the_DT
          main_NN added_JJ lipid_NN )_) and_CC dairy_NN products_NNS (_( 1_CD -_: 2_CD
          servings_NNS /_NN day_NN )_) ,_, (_( b_SYM )_) weekly_JJ consumption_NN :_: of_IN fish_NN (_( 4_CD -_: 5_CD
          servings_NNS /_NN week_NN )_) ,_, poultry_NN (_( 3_CD -_: 4_CD servings_NNS /_NN week_NN )_) ,_, olives_NNS ,_,
          pulses_NNS ,_, and_CC nuts_NNS (_( 3_CD servings_NNS /_NN week_NN )_) ,_, potatoes_NNS ,_, eggs_NNS and_CC
          sweets_NNS (_( 3_CD -_: 4_CD servings_NNS /_NN week_NN )_) and_CC monthly_JJ consumption_NN :_: of_IN
          red_JJ meat_NN and_CC meat_NN products_NNS (_( 4_CD -_: 5_CD servings_NNS /_NN month_NN )_) ._. It_PRP is_VBZ ,_,
          also_RB ,_, characterized_VBN by_IN moderate_JJ consumption_NN of_IN wine_NN (_( 1_CD -_:
          2_CD wineglasses_NNS /_NN day_NN )_) and_CC high_JJ monounsaturated_JJ :_: saturated_VBD
          fat_JJ ratio_NN (_( >_NN 2_LS )_) ._. This_DT dietary_JJ pyramid_NN was_VBD suggested_VBN by_IN
          a_DT Harvard-led_NNP group_NN with_IN substantial_JJ input_NN from_IN Greek_JJ
          scientists_NNS [_NN 13_CD ]_NN ._. Thus_RB ,_, we_PRP measured_VBD the_DT consumption_NN of_IN
          these_DT food_NN items_NNS as_IN an_DT average_NN per_IN week_NN ,_, during_IN the_DT past_JJ
          year_NN ._. Then_RB ,_, the_DT frequency_NN of_IN consumption_NN was_VBD quantified_VBN
          approximately_RB in_IN terms_NNS of_IN the_DT number_NN of_IN times_NNS a_DT month_NN the_DT
          food_NN was_VBD consumed_VBN ._. The_DT weekly_JJ consumption_NN multiplied_VBN by_IN 4_CD
          and_CC a_DT value_NN of_IN 0_CD was_VBD assigned_VBN to_TO food_NN items_NNS rarely_RB or_CC
          never_RB consumed_VBN ._. In_IN order_NN to_TO describe_VB total_JJ diet_NN we_PRP used_VBD
          composite_JJ scores_NNS ,_, which_WDT are_VBP necessary_JJ for_IN the_DT evaluation_NN
          of_IN epidemiological_JJ associations_NNS [_NN 12_CD ]_NN ._. We_PRP defined_VBD
          subjects_NNS who_WP are_VBP "_'' closer_JJR "_'' to_TO the_DT Mediterranean_NNP type_NN of_IN
          diet_NN using_VBG as_IN cut-off_JJ points_VBZ the_DT median_JJ values_NNS of_IN the_DT
          monthly_JJ food_NN consumption_NN score_NN as_IN done_VBN by_IN several_JJ
          investigators_NNS in_IN the_DT past_JJ [_NN 12_CD ]_NN ._. Finally_RB ,_, alcohol_NN
          consumption_NN was_VBD measured_VBN by_IN daily_JJ ethanol_NN intake_NN ,_, in_IN
          wineglasses_NNS (_( 100_CD ml_NN of_IN 12_CD %_NN ethanol_NN concentration_NN )_) ._.
          According_VBG to_TO the_DT collected_VBN medical_JJ information_NN ,_, the_DT
          majority_NN of_IN the_DT controls_NNS (_( 86_CD %_NN )_) and_CC of_IN the_DT patients_NNS (_( 83_CD %_NN )_)
          had_VBD at_IN least_JJS one-laboratory_JJ measurement_NN during_IN the_DT past_JJ
          12_CD months_NNS ._. In_IN addition_NN ,_, we_PRP measured_VBD ,_, both_DT in_IN patients_NNS and_CC
          controls_NNS ,_, arterial_NN blood_NN pressure_NN levels_NNS (_( average_NN of_IN 3_CD
          measurements_NNS with_IN subject_JJ sited_JJ and_CC calm_VB for_IN at_IN least_JJS 30_CD
          minutes_NNS ;_: using_VBG a_DT standard_JJ sphygmomanometer_NN ._. Fast_NNP total_JJ
          cholesterol_NN as_RB well_RB as_RB fast_RB blood_NN glucose_NN levels_NNS were_VBD
          measured_VBN in_IN serum_NN ._. For_IN the_DT cardiac_JJ patients_NNS the_DT
          measurements_NNS were_VBD collected_VBN during_IN the_DT first_JJ 12_CD hours_NNS of_IN
          hospitalisation_NN ,_, and_CC for_IN the_DT controls_NNS at_IN the_DT end_NN of_IN the_DT
          interview_NN ._. The_DT previous_JJ information_NN as_RB well_RB as_IN the_DT
          patients_NNS '_POS and_CC controls_NNS '_POS reports_NNS assisted_VBN us_PRP to_TO
          characterize_VB the_DT subjects_NNS as_IN hypertensive_JJ ,_,
          hypercholesterolemic_JJ and_CC diabetics_NNS ._. In_IN particular_JJ ,_, in_IN
          keeping_VBG with_IN the_DT long-standing_JJ classification_NN criteria_NNS
          used_VBN in_IN several_JJ epidemiological_JJ studies_NNS [_NN 2_CD ]_NN ,_, patients_NNS
          who_WP reported_VBD never_RB having_VBG been_VBN told_VBN of_IN having_VBG
          hypertension_NN and_CC were_VBD not_RB currently_RB taking_VBG any_DT
          antihypertensive_JJ medication_NN and_CC whose_WP$ blood_NN pressure_NN was_VBD
          less_JJR than_IN 140_CD /_NN 90_CD mmHg_NN were_VBD classified_VBN as_IN normotensives_NNS ._.
          Patients_NNS whose_WP$ mean_VB blood_NN pressure_NN levels_NNS were_VBD greater_JJR or_CC
          equal_JJ to_TO 140_CD /_NN 90_CD mmHg_NN or_CC were_VBD under_IN antihypertensive_JJ
          medication_NN were_VBD classified_VBN as_IN hypertensives_NNS ._.
          Hypercholesterolemia_NNP was_VBD defined_VBN ,_, as_IN cholesterol_NN levels_NNS
          greater_JJR than_IN 220_CD mg_NN /_NN dl_NN or_CC greater_JJR than_IN 200_CD mg_NN /_NN dl_NN when_WRB two_CD
          other_JJ risk_NN factors_NNS for_IN coronary_JJ heart_NN disease_NN or_CC use_NN of_IN
          special_JJ hypo-lipidemic_JJ treatment_NN was_VBD present_JJ ._. Diabetics_NNP
          were_VBD those_DT with_IN fast_RB blood_NN glucose_NN greater_JJR than_IN 125_CD mg_NN /_NN dl_NN
          or_CC were_VBD under_IN special_JJ diet_NN or_CC treatment_NN ._. Finally_RB ,_, we_PRP
          measured_VBD the_DT height_NN and_CC the_DT weight_NN both_DT in_IN patients_NNS and_CC
          controls_NNS ._. In_IN addition_NN ,_, we_PRP marked_VBD any_DT significant_JJ changes_NNS
          in_IN their_PRP$ body_NN mass_NN occurred_VBD during_IN the_DT past_JJ years_NNS ._. Thus_RB ,_,
          obesity_NN was_VBD defined_VBN as_IN body_NN mass_NN index_NN (_( weight_NN /_NN {_( height_NN }_)
          2_LS )_) greater_JJR than_IN 29_CD ._. 9_CD Kg_NNP /_NN m_NN 2_CD ._. Current_JJ smokers_NNS were_VBD defined_VBN
          those_DT who_WP smoked_VBD at_IN least_JJS one_CD cigarette_NN per_IN day_NN ._.
          Quantification_NNP of_IN smoking_NN status_NN was_VBD based_VBN on_IN the_DT
          calculation_NN of_IN pack-years_JJ adjusted_VBN for_IN nicotine_NN
          containment_NN equal_JJ to_TO 0_CD ._. 8_CD -_: mgr_NN per_IN cigarette_NN ._. Former_JJ
          smokers_NNS were_VBD defined_VBN as_IN the_DT subjects_NNS who_WP stopped_VBD smoking_VBG
          for_IN over_IN 1_CD year_NN ._. Physical_JJ activity_NN was_VBD defined_VBN as_IN any_DT
          type_NN of_IN leisure_NN time_NN exercise_NN or_CC occupational_NN activity_NN ,_,
          at_IN least_JJS 1_CD /_NN week_NN during_IN the_DT past_JJ year_NN ,_, and_CC was_VBD gradated_JJ in_IN
          qualitative_JJ terms_NNS such_JJ as_IN light_JJ (_( expended_VBN calories_NNS <_NN 4_CD
          Kcal_NNP /_NN min_NN ,_, i_NNP ._. e_SYM ._. walking_VBG slowly_RB ,_, cycling_VBG stationary_JJ ,_, light_JJ
          stretching_VBG etc_FW ._. )_) ,_, moderate_JJ (_( expanded_VBN calories_NNS 4_CD -_: 7_CD Kcal_NNP /_NN
          min_NN ,_, i_NNP ._. e_SYM ._. walking_VBG briskly_RB ,_, cycling_VBG outdoor_JJ ,_, swimming_VBG
          moderate_JJ effort_NN etc_FW ._. )_) and_CC vigorous_JJ (_( expanded_VBN calories_NNS
          >_NN 7_CD Kcal_NNP /_NN min_NN ,_, i_NNP ._. e_SYM ._. walking_VBG briskly_RB uphill_JJ ,_, long_JJ
          distance_NN running_NN ,_, cycling_NN fast_RB or_CC racing_VBG ,_, swimming_NN fast_RB
          crawl_VB etc_FW ._. )_) [_NN 20_CD ]_NN ._. The_DT rest_NN of_IN the_DT subjects_NNS were_VBD
          defined_VBN as_RB physically_RB inactive_JJ ._. Also_RB ,_, the_DT intension_NN and_CC
          the_DT duration_NN of_IN physical_JJ exercise_NN were_VBD taken_VBN into_IN
          account_NN ._. Subject_NNP 's_POS educational_JJ level_NN was_VBD measured_VBN and_CC
          classified_VBN into_IN three_CD groups_NNS :_: Group_NNP I_PRP ,_, up_IN to_TO high_JJ school_NN
          (_( or_CC <_NN 9_CD years_NNS of_IN schooling_NN )_) ;_: Group_NNP II_NNP ,_, high_JJ school_NN ,_,
          technical_JJ school_NN (_( or_CC 9_CD -_: 14_CD years_NNS of_IN eschooling_VBG )_) but_CC not_RB
          university_NN and_CC Group_NNP III_NNP ,_, university_NN ._. Mean_VB annual_JJ income_NN ,_,
          during_IN the_DT past_JJ 5_CD years_NNS was_VBD ,_, also_RB ,_, recorded_VBN ._. Further_RB
          details_NNS regarding_VBG the_DT design_NN and_CC methodology_NN of_IN the_DT
          CARDIO_NNP 2000_CD study_NN have_VBP been_VBN previously_RB presented_VBN [_NN 14_CD 15_CD ]_NN
          ._.
          As_IN previously_RB mentioned_VBN in_IN this_DT work_NN we_PRP focused_VBD our_PRP$
          interest_NN in_IN people_NNS with_IN the_DT metabolic_JJ syndrome_NN ._. According_VBG
          to_TO ATP_NNP III_NNP [_NN 2_CD ]_NN ,_, the_DT diagnosis_NN of_IN metabolic_JJ syndrome_NN
          was_VBD established_VBN if_IN 3_CD or_CC more_JJR of_IN the_DT following_VBG risk_NN
          factors_NNS were_VBD present_JJ :_:
          •_NN waist_NN circumference_NN >_NN 102_CD cm_NN (_( 40_CD in_IN )_) for_IN men_NNS or_CC
          >_NN 88_CD cm_NN (_( 37_CD in_IN )_) for_IN women_NNS ;_:
          •_NN triglyceride_NN level_NN >_NN 150_CD mg_NN /_NN dL_NN ;_:
          •_NN HDL_NNP cholesterol_NN level_NN <_NN 40_CD mg_NN /_NN dL_NN for_IN men_NNS or_CC <_NN 50_CD
          mg_NN /_NN dL_NN for_IN women_NNS ;_:
          •_NN blood_NN pressure_NN >_NN 130_CD /_NN 85_CD mm_NN Hg_NNP ;_:
          •_NN or_CC fasting_VBG glucose_NN >_NN 110_CD mg_NN /_NN dL_NN ._.
        
        
          Statistical_NNP analysis_NN
          Continuous_NNP variables_NNS are_VBP presented_VBN as_IN mean_NN ±_NN one_CD
          standard_JJ deviation_NN while_IN qualitative_JJ variables_NNS are_VBP
          presented_VBN as_IN absolute_JJ and_CC relative_JJ frequencies_NNS ._. In_IN order_NN
          to_TO fit_VB multivariate_NN risk_NN models_NNS an_DT exploratory_JJ analysis_NN
          was_VBD initially_RB applied_VBN ._. Contingency_NNP tables_NNS with_IN
          calculation_NN of_IN chi-squared_JJ test_NN ,_, as_RB well_RB as_IN the_DT
          calculation_NN of_IN Student_NNP 's_POS t-test_JJ were_VBD applied_VBN for_IN the_DT
          evaluation_NN of_IN the_DT associations_NNS between_IN the_DT categorical_JJ
          and_CC continuous_JJ variables_NNS with_IN the_DT outcome_NN ._. Estimations_NNP of_IN
          the_DT relative_JJ risks_NNS of_IN developing_VBG acute_JJ coronary_JJ
          syndromes_NNS ,_, under_IN several_JJ hypotheses_NNS ,_, were_VBD performed_VBN by_IN
          the_DT calculation_NN of_IN the_DT odds_NNS ratio_NN (_( OR_NNP )_) and_CC the_DT
          corresponding_JJ confidence_NN intervals_NNS through_IN multiple_JJ
          logistic_JJ regression_NN analysis_NN ,_, with_IN stepwise_NN elimination_NN
          procedure_NN ._. All_DT reported_VBD P-_NNP values_NNS are_VBP based_VBN on_IN two-sided_JJ
          tests_NNS and_CC compared_VBN to_TO a_DT significant_JJ level_NN of_IN 5_CD %_NN ._. STATA_NNP 6_CD
          software_NN was_VBD used_VBN for_IN the_DT calculations_NNS (_( STATA_NNP Corp_NNP ._.
          College_NNP Station_NNP ,_, Texas_NNP ,_, USA_NNP )_) ._.
        
      
      
        Results_NNS
        
          Descriptive_NNP analysis_NN
          Three_CD hundred_CD and_CC seven_CD (_( 36_CD ._. 2_LS %_NN )_) of_IN the_DT patients_NNS and_CC
          198_CD (_( 18_CD ._. 4_LS %_NN )_) of_IN the_DT controls_NNS (_( P_NN <_NN 0_CD ._. 001_CD )_) met_VBD the_DT ATP_NNP
          III_NNP criteria_NNS ._. The_DT metabolic_JJ syndrome_NN was_VBD more_RBR frequent_JJ in_IN
          males_NNS '_POS than_IN in_IN females_NNS '_POS controls_NNS (_( 22_CD %_NN vs_NNS ._. 10_CD ._. 4_LS %_NN ,_, p_NN <_NN
          0_CD ._. 001_CD )_) ,_, while_IN no_DT statistically_RB significant_JJ differences_NNS
          were_VBD found_VBN regarding_VBG the_DT prevalence_NN of_IN the_DT metabolic_JJ
          syndrome_NN among_IN male_JJ and_CC female_JJ coronary_JJ patients_NNS (_( 37_CD %_NN vs_NNS ._.
          33_CD %_NN ,_, p_NN =_SYM 0_CD ._. 420_CD )_) ._. About_IN the_DT one_CD half_NN of_IN the_DT controls_NNS and_CC
          60_CD %_NN of_IN the_DT patients_NNS with_IN the_DT metabolic_JJ syndrome_NN reported_VBD
          sedentary_JJ life_NN (_( p_NN =_SYM 0_CD ._. 240_CD )_) ._. Current_JJ smoking_NN habits_NNS were_VBD
          highly_RB associated_VBN with_IN the_DT prevalence_NN of_IN the_DT metabolic_JJ
          syndrome_NN ,_, on_IN both_DT ,_, patients_NNS and_CC controls_NNS (_( p_NN <_NN 0_CD ._. 001_CD )_) ._.
          A_DT consistent_JJ inverse_NN association_NN was_VBD observed_VBN between_IN the_DT
          prevalence_NN of_IN the_DT metabolic_JJ syndrome_NN and_CC the_DT financial_JJ
          status_NN of_IN patients_NNS (_( p_NN for_IN trend_NN =_SYM 0_CD ._. 598_CD )_) and_CC controls_NNS (_( p_NN
          for_IN trend_NN =_SYM 0_CD ._. 001_CD )_) ._. No_DT associations_NNS were_VBD observed_VBN
          regarding_VBG the_DT presence_NN of_IN the_DT metabolic_JJ syndrome_NN and_CC the_DT
          educational_JJ profile_NN of_IN the_DT patients_NNS (_( p_NN =_SYM 0_CD ._. 280_CD )_) and_CC the_DT
          controls_NNS (_( p_NN =_SYM 0_CD ._. 136_CD )_) ._. Focusing_VBG our_PRP$ interest_NN on_IN the_DT
          consumption_NN of_IN Mediterranean_NNP diet_NN we_PRP observed_VBD that_IN 80_CD
          (_( 26_CD %_NN )_) of_IN the_DT patients_NNS and_CC 70_CD (_( 35_CD %_NN )_) of_IN the_DT controls_NNS (_( p_NN
          <_NN 0_CD ._. 01_CD )_) that_WDT fulfilled_VBD the_DT criteria_NNS for_IN the_DT metabolic_JJ
          syndrome_NN were_VBD "_'' closer_JJR "_'' to_TO the_DT Mediterranean_NNP diet_NN ._. Table_NNP
          1_CD presents_VBZ the_DT prevalence_NN of_IN hypertension_NN ,_,
          hypercholesterolemia_NN ,_, diabetes_NN mellitus_JJ ,_, physical_JJ
          inactivity_NN ,_, obesity_NN and_CC smoking_NN habits_NNS ,_, in_IN patients_NNS and_CC
          controls_NNS that_WDT adopted_VBD the_DT Mediterranean_NNP diet_NN compared_VBN to_TO
          patients_NNS and_CC controls_NNS that_IN they_PRP did_VBD not_RB adopt_VB this_DT diet_NN ._.
          These_DT associations_NNS raise_VBP the_DT confounding_VBG effect_NN of_IN the_DT
          adoption_NN of_IN the_DT Mediterranean_NNP diet_NN on_IN obesity_NN ,_, physical_JJ
          activity_NN and_CC smoking_NN habits_NNS ._. Moreover_RB ,_, both_DT patients_NNS and_CC
          controls_NNS that_WDT were_VBD defined_VBN "_'' closer_JJR "_'' to_TO the_DT Mediterranean_NNP
          diet_NN had_VBD lower_JJR prevalence_NN of_IN the_DT conventional_JJ
          cardiovascular_JJ risk_NN factors_NNS compared_VBN to_TO the_DT rest_NN of_IN the_DT
          subjects_NNS (_( Table_NNP 1_LS )_) ._.
        
        
          Risk_NN stratification_NN
          Multivariate_NNP analysis_NN revealed_VBD that_IN the_DT metabolic_JJ
          syndrome_NN 2_CD fold_VB the_DT coronary_JJ risk_NN (_( odds_NNS ratio_NN =_SYM 2_CD ._. 35_CD ,_, 95_CD %_NN
          1_CD ._. 87_CD -_: 2_CD ._. 84_CD )_) after_IN adjustment_NN for_IN age_NN ,_, sex_NN ,_, physical_JJ
          activity_NN levels_NNS ,_, smoking_NN habits_NNS ,_, financial_JJ status_NN and_CC
          presence_NN of_IN hypertension_NN ,_, hypercholesterolemia_NN ,_, and_CC
          diabetes_NN mellitus_JJ ._. However_RB ,_, the_DT unadjusted_JJ odds_NNS ratio_NN for_IN
          developing_VBG an_DT acute_JJ coronary_JJ event_NN in_IN people_NNS who_WP adopted_VBD
          the_DT Mediterranean_NNP diet_NN was_VBD 0_CD ._. 64_CD (_( 95_CD %_NN CI_NNP 0_CD ._. 44_CD -_: 0_CD ._. 95_CD )_) ,_,
          indicating_VBG a_DT 36_CD %_NN reduction_NN of_IN the_DT coronary_JJ risk_NN as_IN
          compared_VBN with_IN people_NNS that_WDT did_VBD not_RB adopt_VB this_DT diet_NN ._. After_IN
          taking_VBG into_IN account_NN the_DT effect_NN of_IN the_DT aforementioned_JJ
          associations_NNS (_( descriptive_JJ analysis_NN )_) as_RB well_RB as_IN the_DT effect_NN
          of_IN several_JJ potential_JJ confounders_NNS ,_, like_IN age_NN and_CC sex_NN of_IN the_DT
          participants_NNS ,_, systolic_JJ and_CC diastolic_JJ blood_NN pressures_NNS ,_,
          total_JJ serum_NN cholesterol_NN and_CC blood_NN glucose_NN levels_NNS ,_, as_RB well_RB
          as_IN premature_JJ family_NN history_NN of_IN coronary_JJ heart_NN disease_NN ,_, we_PRP
          found_VBD that_DT effect_NN of_IN the_DT consumption_NN of_IN Mediterranean_NNP
          diet_NN on_IN the_DT coronary_JJ risk_NN remains_VBZ beneficial_JJ ._. In_IN
          particular_JJ ,_, the_DT adoption_NN of_IN this_DT diet_NN is_VBZ associated_VBN with_IN
          a_DT 23_CD %_NN (_( odds_NNS ratio_NN =_SYM 0_CD ._. 77_CD ,_, Table_NNP 2_LS )_) reduction_NN of_IN the_DT
          coronary_JJ risk_NN in_IN subjects_NNS with_IN the_DT metabolic_JJ syndrome_NN ._.
          The_DT calculated_VBN attributable_JJ risk_NN by_IN the_DT formula_NN :_:
          attributable_JJ risk_NN =_SYM (_( odds_NNS ratio_NN -_: 1_LS )_) /_NN odds_NNS ratio_NN [_NN 11_CD ]_NN
          ,_, suggested_VBD that_IN the_DT one_CD third_JJ (_( 30_CD %_NN )_) of_IN the_DT acute_JJ
          coronary_JJ events_NNS could_MD be_VB prevented_VBN by_IN the_DT adoption_NN of_IN the_DT
          Mediterranean_NNP diet_NN ,_, in_IN subjects_NNS with_IN the_DT metabolic_JJ
          syndrome_NN ._. Moreover_RB ,_, the_DT adoption_NN of_IN Mediterranean_NNP diet_NN by_IN
          people_NNS who_WP reported_VBD that_IN they_PRP exercise_VBP at_IN least_JJS once_RB per_IN
          week_NN (_( >_NN 4_CD kcal_NN /_NN min_NN )_) seems_VBZ to_TO have_VB an_DT additive_JJ benefit_NN ,_,
          since_IN it_PRP is_VBZ associated_VBN with_IN 47_CD %_NN (_( odds_NNS ratio_NN =_SYM 0_CD ._. 53_CD ,_, P_NN
          <_NN 0_CD ._. 01_CD )_) lower_JJR risk_NN of_IN developing_VBG acute_JJ coronary_JJ
          events_NNS ,_, after_IN adjusting_VBG for_IN age_NN ,_, sex_NN ,_, and_CC the_DT levels_NNS of_IN
          the_DT common_JJ cardiovascular_JJ risk_NN factors_NNS ._. This_DT reduction_NN of_IN
          the_DT coronary_JJ risk_NN is_VBZ much_RB higher_JJR than_IN Mediterranean_NNP diet_NN
          or_CC exercise_NN (_( odds_NNS ratio_NN =_SYM 0_CD ._. 89_CD ,_, p_NN <_NN 0_CD ._. 05_CD )_) achieve_VB
          alone_RB in_IN this_DT group_NN of_IN people_NNS ._.
        
      
      
        Discussion_NNP
        In_IN this_DT work_NN we_PRP evaluated_VBD the_DT effect_NN of_IN the_DT adoption_NN of_IN
        Mediterranean_NNP diet_NN on_IN the_DT development_NN of_IN acute_JJ coronary_JJ
        syndromes_NNS ,_, in_IN subject_JJ with_IN the_DT metabolic_JJ syndrome_NN ._. The_DT data_NNS
        analysis_NN revealed_VBD that_IN the_DT adoption_NN of_IN the_DT Mediterranean_NNP
        diet_NN is_VBZ associated_VBN with_IN a_DT considerable_JJ reduction_NN of_IN the_DT
        coronary_JJ risk_NN ,_, in_IN these_DT people_NNS ,_, after_IN adjustment_NN for_IN
        several_JJ potential_JJ confounders_NNS ._.
        The_DT metabolic_JJ syndrome_NN is_VBZ a_DT condition_NN well_RB established_VBD
        in_IN nowadays_RB ,_, and_CC it_PRP is_VBZ associated_VBN with_IN the_DT promotion_NN of_IN
        atherosclerosis_NNS and_CC increase_NN of_IN the_DT cardiovascular_JJ risk_NN ._.
        Moreover_RB ,_, there_EX is_VBZ extensive_JJ scientific_JJ evidence_NN ,_,
        especially_RB in_IN countries_NNS with_IN better_JJR and_CC long_JJ lasting_JJ
        national_JJ health_NN programs_NNS ,_, that_IN the_DT prevalence_NN of_IN metabolic_JJ
        syndrome_NN has_VBZ increased_VBN in_IN the_DT last_JJ decade_NN ,_, which_WDT suggest_VBP
        that_IN the_DT disease_NN burden_NN (_( including_VBG type_NN 2_CD diabetes_NN )_) has_VBZ
        increased_VBN as_RB well_RB [_NN 1_CD ]_NN ._. Despite_IN its_PRP$ multiple_JJ origins_NNS ,_,
        obesity_NN ,_, sedentary_JJ life_NN coupled_VBN with_IN unhealthy_JJ diet_NN and_CC
        genetic_JJ factors_NNS interact_NN to_TO produce_VB this_DT syndrome_NN ._. ATP_NNP III_NNP
        raised_VBD the_DT significance_NN of_IN diagnosing_VBG and_CC treating_VBG the_DT
        metabolic_JJ syndrome_NN ,_, focusing_VBG on_IN physical_JJ activity_NN ,_, lowering_VBG
        excess_JJ body_NN fat_JJ and_CC on_IN specific_JJ dietary_JJ patterns_NNS ._. During_IN
        the_DT past_JJ years_NNS several_JJ epidemiological_JJ studies_NNS have_VBP
        underlined_VBD the_DT relation_NN between_IN diet_NN and_CC incidence_NN of_IN
        coronary_JJ heart_NN disease_NN ,_, and_CC other_JJ diseases_NNS [_NN 16_CD 17_CD 18_CD ]_NN ._.
        Dietary_NNP factors_NNS exert_VB their_PRP$ influence_NN largely_RB through_IN their_PRP$
        effects_NNS on_IN blood_NN lipids_NNS and_CC lipoproteins_NNS ,_, as_RB well_RB as_IN on_IN the_DT
        other_JJ established_VBN modifiable_JJ risk_NN factors_NNS ,_, with_IN the_DT
        exception_NN of_IN cigarette_NN smoking_NN ._. Our_PRP$ findings_NNS support_VBP the_DT
        hypothesis_NNS that_WDT adoption_NN of_IN Mediterranean_NNP diet_NN by_IN subjects_NNS
        who_WP met_VBD the_DT criteria_NNS for_IN the_DT metabolic_JJ syndrome_NN is_VBZ
        associated_VBN with_IN a_DT significant_JJ reduction_NN of_IN the_DT risk_NN of_IN
        developing_VBG acute_JJ coronary_JJ events_NNS ._. The_DT investigated_VBN type_NN of_IN
        diet_NN is_VBZ low_JJ in_IN saturated_VBD fat_JJ ,_, high_JJ in_IN monounsaturated_JJ fat_NN ,_,
        mainly_RB from_IN olive_JJ oil_NN ,_, high_JJ in_IN complex_JJ carbohydrates_NNS ,_, from_IN
        legumes_NNS ,_, and_CC high_JJ in_IN fibre_NN ,_, mostly_RB from_IN vegetables_NNS and_CC
        fruits_NNS ._. Also_RB ,_, epidemiological_JJ studies_NNS suggest_VBP that_IN the_DT
        Mediterranean_NNP diet_NN is_VBZ associated_VBN with_IN lower_JJR coronary_JJ heart_NN
        disease_NN risk_NN ,_, especially_RB through_IN the_DT reduction_NN of_IN blood_NN
        pressures_NNS ,_, body_NN mass_NN index_NN ,_, and_CC levels_NNS of_IN several_JJ
        thrombogenic_JJ factors_NNS [_NN 12_CD 13_CD 18_CD 19_CD ]_NN ._. Recently_RB ,_, the_DT
        findings_NNS from_IN the_DT Lyon_NNP Diet_NNP Heart_NNP study_NN illustrate_VBP the_DT
        potential_JJ importance_NN of_IN the_DT Mediterranean_NNP dietary_JJ pattern_NN ,_,
        especially_RB when_WRB compared_VBN to_TO other_JJ recommended_VBD diets_NNS ,_, like_IN
        Step-_NNP I_PRP diet_NN [_NN 19_CD ]_NN ._. Also_RB ,_, results_NNS from_IN a_DT Spanish_NNP Study_NNP
        suggest_VBP that_IN the_DT monounsaturated_JJ fatty_NN acids_NNS diets_NNS are_VBP
        associated_VBN with_IN a_DT significant_JJ reduction_NN and_CC a_DT better_JJR
        control_NN of_IN both_DT systolic_JJ and_CC diastolic_JJ blood_NN pressure_NN [_NN 20_CD
        ]_NN ._. However_RB it_PRP still_RB remains_VBZ a_DT matter_NN of_IN debate_NN if_IN the_DT
        protective_JJ influence_NN is_VBZ primarily_RB caused_VBN by_IN single_JJ
        nutrients_NNS ,_, e_SYM ._. g_SYM ._. dietary_JJ fatty_NN acids_NNS ,_, potassium_NN or_CC dietary_JJ
        fibre_NN or_CC if_IN it_PRP can_MD be_VB attributed_VBN to_TO the_DT Mediterranean_NNP diet_NN
        as_IN a_DT whole_JJ [_NN 12_CD ]_NN ._.
        EUROASPIRE_NNP Study_NNP group_NN investigators_NNS suggest_VBP to_TO the_DT
        cardiologists_NNS ,_, physicians_NNS and_CC public_JJ health_NN policy_NN makers_NNS
        to_TO moderate_VB the_DT prevalence_NN of_IN the_DT cardiovascular_JJ risk_NN
        factors_NNS in_IN order_NN to_TO further_VB reduce_VB coronary_JJ heart_NN disease_NN
        morbidity_NN and_CC mortality_NN and_CC improve_VB patient_NN 's_POS chances_NNS of_IN
        survival_NN [_NN 21_CD ]_NN ._. This_DT reduction_NN may_MD be_VB achieved_VBN through_IN
        the_DT adoption_NN of_IN a_DT healthier_JJR lifestyle_NN ,_, including_VBG stopping_VBG
        smoking_NN ,_, initiation_NN of_IN physical_JJ activities_NNS and_CC adoption_NN of_IN
        a_DT healthy_JJ diet_NN ._. Recently_RB the_DT NCEP_NNP ATP_NNP III_NNP recommended_VBD for_IN 
        Therapeutic_NNP Lifestyle_NNP Changes_NNS [_NN 2_CD ]_NN
        in_IN order_NN to_TO reduce_VB the_DT prevalence_NN of_IN the_DT metabolic_JJ syndrome_NN
        among_IN populations_NNS ._. These_DT changes_NNS underlined_VBD the_DT importance_NN
        of_IN low-saturated_JJ diet_NN consumption_NN (_( <_NN 7_CD %_NN of_IN total_JJ fat_JJ )_) and_CC
        physical_JJ exercise_NN ._. In_IN our_PRP$ work_NN we_PRP found_VBD that_IN the_DT adoption_NN
        of_IN Mediterranean_NNP diet_NN seems_VBZ to_TO be_VB associated_VBN with_IN a_DT
        considerable_JJ reduction_NN of_IN acute_JJ coronary_JJ events_NNS (_( i_NNP ._. e_SYM ._. 30_CD %_NN )_)
        in_IN people_NNS with_IN the_DT metabolic_JJ syndrome_NN ._. Interestingly_RB ,_, is_VBZ
        that_IN the_DT adoption_NN of_IN Mediterranean_NNP diet_NN by_IN physically_RB
        active_JJ people_NNS is_VBZ associated_VBN with_IN much_RB higher_JJR reduction_NN of_IN
        the_DT odds_NNS of_IN developing_VBG acute_JJ coronary_JJ event_NN ,_, than_IN diet_NN or_CC
        exercise_NN achieve_VB alone_RB ._. A_DT plausible_JJ explanation_NN could_MD be_VB
        the_DT low_JJ concentration_NN of_IN this_DT type_NN of_IN diet_NN in_IN saturated_VBD fat_JJ
        and_CC the_DT non-lipid-lowering_JJ benefits_NNS that_IN physical_JJ
        activities_NNS and_CC Mediterranean_NNP diet_NN have_VBP been_VBN reported_VBN to_TO
        produce_VB (_( including_VBG antithrombotic_JJ and_CC anti-inflammatory_JJ
        effects_NNS )_) [_NN 22_CD 23_CD ]_NN ._. In_IN accordance_NN to_TO that_DT ,_, several_JJ
        investigators_NNS have_VBP reported_VBN that_IN non-pharmacological_JJ
        lifestyle_NN interventions_NNS ,_, like_IN diet_NN and_CC exercise_NN ,_, could_MD be_VB
        useful_JJ in_IN the_DT management_NN of_IN hypertensive_JJ subjects_NNS [_NN 24_CD 25_CD ]_NN
        ._.
        This_DT is_VBZ the_DT first_JJ study_NN concerning_VBG the_DT prevalence_NN of_IN the_DT
        metabolic_JJ syndrome_NN in_IN Greece_NNP and_CC the_DT effect_NN of_IN the_DT
        Mediterranean_NNP diet_NN on_IN the_DT related_VBN coronary_JJ risk_NN ._. The_DT
        results_NNS of_IN our_PRP$ study_NN suggest_VBP that_IN one_CD third_NN of_IN the_DT acute_JJ
        coronary_JJ events_NNS could_MD be_VB prevented_VBN by_IN the_DT adoption_NN of_IN the_DT
        Mediterranean_NNP diet_NN in_IN subjects_NNS with_IN the_DT metabolic_JJ syndrome_NN ._.
        Education_NNP and_CC training_NN will_MD be_VB critical_JJ to_TO ensure_VB that_IN
        physicians_NNS have_VBP knowledge_NN to_TO diagnose_NN and_CC treat_VB patients_NNS
        with_IN the_DT metabolic_JJ syndrome_NN ._. So_IN the_DT early_JJ identification_NN ,_,
        treatment_NN (_( with_IN non_NN pharmacological_JJ interventions_NNS )_) and_CC
        prevention_NN of_IN the_DT metabolic_JJ syndrome_NN seems_VBZ to_TO be_VB extremely_RB
        challenging_VBG and_CC provoking_VBG for_IN the_DT health_NN policy_NN makers_NNS ,_, in_IN
        order_NN to_TO reduce_VB the_DT epidemic_NN of_IN overweight_NN ,_, improper_JJ
        nutrition_NN and_CC sedentary_JJ lifestyle_NN ._. However_RB ,_, even_RB the_DT
        observed_VBN association_NN is_VBZ independent_JJ from_IN several_JJ potential_JJ
        confounders_NNS it_PRP is_VBZ hard_JJ to_TO claim_VB that_IN our_PRP$ findings_NNS suggest_VBP
        causal_NN evidence_NN and_CC much_JJ remains_VBZ to_TO be_VB learned_VBN about_IN this_DT
        "_'' ecological_JJ "_'' effect_NN on_IN coronary_JJ risk_NN in_IN people_NNS with_IN the_DT
        metabolic_JJ syndrome_NN ._.
      
      
        Limitations_NNPS of_IN the_DT study_NN
        In_IN retrospective_NN case-control_JJ studies_NNS ,_, two_CD main_JJ sources_NNS
        of_IN systematic_JJ errors_NNS may_MD exist_VB ,_, the_DT selection_NN and_CC the_DT
        recall_NN bias_NN ._. In_IN order_NN to_TO eliminate_VB selection_NN bias_NN we_PRP tried_VBD
        to_TO set_VB objective_NN criteria_NNS ,_, both_DT for_IN patients_NNS and_CC controls_NNS ._.
        However_RB ,_, insignificant_JJ misclassification_NN may_MD exist_VB ,_, since_IN a_DT
        small_JJ percentage_NN of_IN asymptomatic_JJ coronary_JJ patients_NNS may_MD be_VB
        wrongly_RB assigned_VBN to_TO controls_NNS ,_, even_RB if_IN they_PRP were_VBD evaluated_VBN
        by_IN a_DT cardiologist_NN ._. Also_RB ,_, in_IN case-control_JJ studies_NNS ,_, it_PRP is_VBZ
        usually_RB observed_VBN that_IN patients_NNS who_WP had_VBD a_DT recent_JJ adverse_JJ
        event_NN are_VBP more_RBR likely_JJ to_TO place_VB greater_JJR emphasis_NN
        (_( overestimate_NN )_) on_IN several_JJ factors_NNS related_VBN to_TO the_DT disease_NN
        than_IN the_DT control_NN group_NN (_( recall_VB bias_NN )_) ._. In_IN order_NN to_TO reduce_VB
        this_DT type_NN of_IN bias_NN and_CC analyze_VB accurate_JJ information_NN we_PRP made_VBD
        an_DT effort_NN to_TO obtain_VB accurate_JJ information_NN from_IN the_DT patients_NNS
        as_RB well_RB as_IN from_IN their_PRP$ relatives_NNS or_CC their_PRP$ accompanying_VBG
        persons_NNS ._. However_RB ,_, overestimation_NN of_IN the_DT effect_NN of_IN the_DT
        investigated_VBN combination_NN may_MD still_RB exist_VB ._. Concerning_VBG the_DT
        medical_JJ information_NN ,_, we_PRP tried_VBD to_TO avoid_VB recall_VB bias_NN by_IN
        obtaining_VBG accurate_JJ and_CC detailed_JJ data_NNS from_IN subjects_VBZ medical_JJ
        records_NNS ._. However_RB ,_, over_IN /_NN under_IN estimation_NN may_MD still_RB exist_VB ,_,
        especially_RB in_IN the_DT measurement_NN of_IN nutritional_JJ and_CC smoking_NN
        habits_NNS ,_, and_CC the_DT onset_NN of_IN the_DT investigated_VBN cardiovascular_JJ
        risk_NN factors_NNS ._. Moreover_RB ,_, the_DT coronary_JJ patients_NNS who_WP died_VBD at_IN
        entry_NN or_CC the_DT day_NN after_IN were_VBD not_RB included_VBN in_IN the_DT study_NN ._. This_DT
        bias_NN could_MD influence_VB our_PRP$ results_NNS ,_, but_CC ,_, since_IN the_DT proportion_NN
        of_IN deaths_NNS during_IN the_DT first_JJ two_CD days_NNS was_VBD estimated_VBN between_IN
        2_CD -_: 4_CD %_NN ,_, we_PRP believe_VBP that_IN the_DT inability_NN to_TO include_VB the_DT fatal_JJ
        events_NNS did_VBD not_RB alter_VB significantly_RB our_PRP$ findings_NNS ._.
        Furthermore_RB ,_, regarding_VBG the_DT potential_JJ effect_NN of_IN uncontrolled_JJ
        -_: unknown_JJ confounders_NNS ,_, we_PRP tried_VBD to_TO reduce_VB it_PRP using_VBG the_DT same_JJ
        study_NN base_NN ,_, both_DT for_IN patients_NNS and_CC controls_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Contribution_NNP of_IN authors_NNS
        CP_NNP :_: design_NN of_IN the_DT study_NN and_CC drafted_VBD the_DT manuscript_NN ,_, DP_NNP :_:
        design_NN of_IN the_DT study_NN ,_, data_NNS analysis_NN and_CC drafted_VBD the_DT
        manuscript_NN ,_, CC_NNP :_: design_NN of_IN the_DT study_NN ,_, IP_NNP :_: drafted_VBD the_DT
        manuscript_NN ,_, LP_NNP :_: drafted_VBD the_DT manuscript_NN ,_, DT_NNP :_: drafted_VBD the_DT
        manuscript_NN ,_, PT_NNP :_: design_NN of_IN the_DT study_NN and_CC CS_NNP :_: design_NN of_IN the_DT
        study_NN ._.
      
    
  
